Patent Expiry

Patent/Exclusivity Expiry: DRIZALMA SPRINKLE

Other upcoming events for IVA

Phase 3 ReadoutPhase 3 Topline: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and S

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: DRIZALMA SPRINKLE — IVA Patent Expiry | BioSniper